A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2002
10/24/2002	US20020155581 Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
10/24/2002	US20020155577 Compound for use in the treatment of parkinson's disease
10/24/2002	US20020155562 Glutathionylspermidine synthetase and processes for recovery and use thereof
10/24/2002	US20020155552 "prionins", highly specific markers for noninvasive pre-symptomatic detection of tse diseases, and targets for therapeutic reagents to prevent and control tse diseases in animals and humans
10/24/2002	US20020155545 Chemokines expressed in pancreas
10/24/2002	US20020155537 Method for making heteromultimeric polypeptides
10/24/2002	US20020155528 Regulation of human CysLT2-like GPCR protein
10/24/2002	US20020155527 Nucleotide sequences coding membrane protein for use in the treatment of tumors
10/24/2002	US20020155519 Human blood bacterium
10/24/2002	US20020155510 Dendritic cell-specific antibodies
10/24/2002	US20020155506 Human IL-1 epsilon DNA and polypeptides
10/24/2002	US20020155498 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
10/24/2002	US20020155468 Ovarian tumor antigen and methods of use therefor
10/24/2002	US20020155447 Nucleotide sequences coding polypeptide for use in the treatment of cancer
10/24/2002	US20020155441 Polypeptides for use in the, detection, prevention, treatment and diagnosis of malarial infection
10/24/2002	US20020155436 Immunizing mammals aganist infection; obtain mammal, expose to antigen, generate antibody, monitor response in infection
10/24/2002	US20020155434 Fusion protein for use in the treatment of viral diseases
10/24/2002	US20020155433 Polypeptide for use the prevention of infections associated with tissue grafting
10/24/2002	US20020155428 Retrovirus from the HIV group and its use
10/24/2002	US20020155181 Method and composition for improving sexual fitness
10/24/2002	US20020155135 Method of making patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes
10/24/2002	US20020155134 Dermatomycosis vaccine
10/24/2002	US20020155131 Recombinant equine herpesvirus type 1 (EHV-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine
10/24/2002	US20020155130 To immunity to mammals from infection and/or disease caused by a lentivirus, such as equine infectious anemia virus, human immunodeficiency virus (HIV), feline immunodeficiency virus, bovine immunodeficiency virus or simian immunodeficiency virus
10/24/2002	US20020155129 Simple non-toxic system, deliverable by syringe or needle-free systems, is inexpensive and reliable and aids in parenteral drug delivery or mass immunization campaigns by reducing need for repeated injections
10/24/2002	US20020155128 Inactivated bovine scours vaccines, processes and method of preventing bovine scours
10/24/2002	US20020155127 Genetic vaccine against human immunodeficiency virus
10/24/2002	US20020155125 Compositions and methods for therapy and diagnosis of breast cancer
10/24/2002	US20020155124 For enhancing the effect of vaccines in animals, such as domestic, sport, or pet species, and humans
10/24/2002	US20020155123 Compositions and methods for inhibiting HIV infection
10/24/2002	US20020155122 Immunologically significant herpes simplex virus antigens and methods for identifying and using same
10/24/2002	US20020155121 Virus coat protein/receptor chimeras and methods of use
10/24/2002	US20020155120 Protein and peptide vaccines for inducing mucosal immunity
10/24/2002	US20020155118 Alkaloid glycoside for use as a medicament
10/24/2002	US20020155117 Method for detecting organ allograft rejection and uses thereof
10/24/2002	US20020155116 Autogenous vaccine derived from one's own hypothalamus of the brain & kidney's via a process known as liquefaction
10/24/2002	US20020155115 Cancer therapy
10/24/2002	US20020155108 Obtaining peripheral blood mononuclear cells; depleting lymphocytes; incubating with cytokines to expand and form dendritic cells; incubating dendritic cells in presence of target cell and antibody against soluble antigens
10/24/2002	US20020155107 Methods and formulations for reducing circulating antibodies
10/24/2002	US20020155104 Altering T cell mediated immunity comprising altering local extracellular concentrations of tryptophan and tryptophan metabolites
10/24/2002	US20020155093 Administering immunologically-effective amount of therapeutic differentiation antigen of same type as target differentiation antigen, wherein therapeutic differentiation antigen is produced by expression in cells of second species
10/24/2002	DE10119804A1 New peptides produced in primates during inflammation and sepsis, useful for diagnosis and treatment of these diseases, and their related antibodies
10/24/2002	DE10116042A1 Exotoxin-Ligand Exotoxin-ligand
10/24/2002	CA2446921A1 Selective covalent-binding compounds having therapeutic diagnostic and analytical applications
10/24/2002	CA2444632A1 Vascular endothelial growth factor 2
10/24/2002	CA2444377A1 Method of intradermally injecting substances
10/24/2002	CA2444264A1 Prodrugs via acylation with cinnamate
10/24/2002	CA2444262A1 Bifunctional energy-reversible acyl-compositions
10/24/2002	CA2444133A1 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	CA2444048A1 Novel immunogenic compositions comprising modified and unmodified antigens
10/24/2002	CA2444001A1 Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby
10/24/2002	CA2443995A1 Endothelial cell expression patterns
10/24/2002	CA2443912A1 Vaccines including as an adjuvant type 1 ifn and processes related thereto
10/24/2002	CA2443903A1 Antibodies to vla-1
10/24/2002	CA2443777A1 Therapeutic and diagnostic uses of antibody specificity profiles
10/24/2002	CA2443705A1 Cyclic single strand trispecific antibody
10/24/2002	CA2443525A1 Human cellular protein gastrointestinal glutathione peroxidase as target for medical intervention against hepatitis c virus infections
10/24/2002	CA2443493A1 Surface proteins of streptococcus pyogenes
10/24/2002	CA2443147A1 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002	CA2443141A1 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	CA2443123A1 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002	CA2443088A1 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
10/24/2002	CA2442943A1 Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers
10/24/2002	CA2441699A1 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives
10/24/2002	CA2438107A1 G-protein coupled receptor molecules and uses thereof
10/24/2002	CA2430322A1 Use of clya hemolysin for excretion of proteins
10/23/2002	EP1251176A2 Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide
10/23/2002	EP1251139A2 Human mindin-like protein and nucleic acids encoding it
10/23/2002	EP1251138A1 Prion protein dimers useful for vaccination
10/23/2002	EP1250933A1 Vaccines including as an adjuvant high dose type I IFN
10/23/2002	EP1250436A1 Toll-like receptor
10/23/2002	EP1250434A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
10/23/2002	EP1250429A2 Human sperm specific lysozyme-like proteins
10/23/2002	EP1250425A2 Secreted human proteins, polynucleotides encoding them and methods of using the same
10/23/2002	EP1250421A1 Recombinant flaviviruses and methods of use thereof
10/23/2002	EP1250150A2 Innate immunity-stimulating compositions of cpg and saponin and methods thereof
10/23/2002	EP1250149A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer
10/23/2002	EP1250146A2 Use of neurotoxins for treating diabetes
10/23/2002	EP1250145A1 C-ski oncogene-derived peptides for prevention, treatment, and diagnosis of cancer
10/23/2002	EP1250135A1 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
10/23/2002	EP1070255A4 Assay of igfbp complex
10/23/2002	EP0920449B1 Morbillivirus-derived peptides
10/23/2002	EP0858345B1 Use of muteins of wild-type cytokines as immunogens
10/23/2002	EP0766745B1 Monoclonal antibody specific for human 4-1bb and cell line producing same
10/23/2002	EP0750510B1 Anti-acne skin treatment composition
10/23/2002	EP0721470B1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer
10/23/2002	EP0642581B1 Clostridium perfringens vaccines
10/23/2002	CN1376201A Immunologically significant herpes simplex virus antigens
10/23/2002	CN1376200A DNA vaccine-PCV
10/23/2002	CN1376197A Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension
10/23/2002	CN1376158A Oligosaccharides derived from ribose-ribitol-phosphate, and vaccines containing them
10/23/2002	CN1376073A Method of expressing antigen on the surface of an antigen-presenting cell by photochemical internalisation
10/23/2002	CN1376056A Liposome-entrapped DNA oral vaccines
10/23/2002	CN1093172C Hepatitis C virus and its external cell culture method
10/23/2002	CA2382993A1 Attenuated recombinant rabies virus mutants and live vaccines thereof
10/22/2002	US6469152 Flea allantoinase nucleic acid molecules, proteins and uses thereof
10/22/2002	US6469144 Apo-2li (apo-2 ligand inhibitor, related to apoptosis) monoclonal antibodies
10/22/2002	US6469139 Point mutations; for use as immunological contragestatives; pregnancy prevention
10/22/2002	US6468984 DNA vaccine for protecting an avian against infectious bursal disease virus
10/22/2002	US6468982 Orally administering composition comprising bupivacaine and dna molecules comprising dna sequence encoding antigen linked to regulatory sequences which control expression; cellsexpressing sequence generate immune response against

1 ... 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 ... 1823